| Financial Year |
March 31 2023 |
| Monetary Funds |
664,480,438.93 |
| Held-for-trading Financial Assets |
564,924.60 |
| Notes Receivable |
26,812,818.88 |
| Accounts Receivable |
975,627,946.97 |
| Advances to Suppliers |
464,174.80 |
| Other Receivables |
320,061,843.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
8,343,178.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
230,965,026.94 |
| Other Current Assets |
13,478,010.31 |
| Total Current Assets |
7,598,041,964.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
625,933,478.92 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
17,402,068.47 |
| Under-construction Projects |
3,933,153.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
46,196,060.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,240,734.67 |
| Deferred Income Tax Assets |
68,495,639.48 |
| Other Non-Current Assets |
709,991,522.77 |
| Sub-Total of Non-Current Assets |
1,554,446,500.14 |
| Total Assets |
9,152,488,465.02 |
| Short-Term Loans |
595,860,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
371,821,109.00 |
| Accounts Payable |
3,927,159,935.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,816,405.75 |
| Taxes Payable |
26,794,973.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
146,035,612.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,182,579.28 |
| Other Current Liabilities |
230,062,153.28 |
| Sub-Total of Current Liabilities |
5,323,732,769.40 |
| Long-term Loans |
108,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
113,024,355.10 |
| Total Liabilities |
5,436,757,124.50 |
| Paid-In Capital(Or Share Stock) |
446,096,000.00 |
| Capital Surplus |
921,469,223.71 |
| Surplus Reserve |
216,986,831.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,048,908,291.28 |
| Minority Stockholder's Interest |
82,270,994.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,633,460,346.21 |
| Owner's Equity（Stockholder's Equity） |
3,715,731,340.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,152,488,465.02 |
